Menu
Recruiting NCT07236580

Buteyko Breathing and Approach of Smoking Hygiene: Effects on Dysfucntion of Eustachian Tube and Lung Functions

No phase Interventional Tobacco Smoking Eustachian Tube Dysfunction

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Buteyko breathing plus smoking hyeigne approach, smoking hygiene appraoch.
Who it may be relevant to
Registry conditions: Tobacco Smoking, Eustachian Tube Dysfunction. Basic parameters: 13 years — 17 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Is There Efficacy of Adding Buteyko Breathing to Approach of Smoking Hygiene on Dysfucntion of Eustachian Tube and Lung Functions in Adolescnets Who Are Passively Exposed to Tobacco Smoke?

Overview

adolescents are usually exposed to tobacco smoke passively. this can reduce their lung functions and negatively impact functions of Eustachian tube. The solution is to lower rates to tobacco exposure and use the support of Buteyko Breathing

Detailed description

in this study, we will randolmly recruit 40 adolescents who are usually exposed to tobacco smoke passively in house from smoking parent or household members. these adolescents will complain chronic dysfunction of their Eustachian Tube (chronic obstructive dysfucntion) . adolescents will be catagorized to one of both groupsl, group I or group II (N=20 patient in the group). Both groups will receive smokinh hyeigne approach for 6 months. Group I will additionally receive Buteyko Breathing 30-minute apprach (this appraoch will be appleid by patients all days, except fridays, weekly for 6 months).

Interventions

  • Behavioral Buteyko breathing plus smoking hyeigne approach
    in this group, we will include 20 adolescents who are usually exposed to tobacco smoke passively in house from smoking parent or household members. these adolescents will complain chronic dysfunction of their Eustachian Tube (chronic obstructive dysfucntion) . adolescents will receive smoking hyeigne approach for 6 months.This group will additionally receive Buteyko Breathing 30-minute apprach (this appraoch will be appleid by patients all days weekly, except fridays, for 6 months).
  • Behavioral smoking hygiene appraoch
    in this group, we will include 20 adolescents who are usually exposed to tobacco smoke passively in house from smoking parent or household members. these adolescents will complain chronic dysfunction of their Eustachian Tube (chronic obstructive dysfucntion) . adolescents will receive smoking hyeigne approach for 6 months.

Primary outcome measures

  • Eustachian Tube dyafucntion questionaire [Time frame: it will be measured after 6 months]
Secondary outcome measures (6)
  • percentage of change in type of tympanmetery [Time frame: it will be measured after 6 months]
  • forced vital capcity [Time frame: it will be measured after 6 months]
  • force expiratory volume (FEV1) [Time frame: it will be measured after 6 months]
  • FEV1/FVC [Time frame: it will be measured after 6 monthd]
  • physical summary of parent form child health questinaire [Time frame: it will be measured after 6 months]
  • mental summary of parent form child health questinaire [Time frame: it will be measured after 6 months]

Eligibility criteria

Inclusion criteria

  • Dysfucntion of Eustachian Tube (obstructive chronic form)
  • adolescents with passive tobacco exposure from smoking parent or household member
  • adolscent participants whose parents approve the participation

Exclusion criteria

  • cardiac problem
  • chest disease
  • renal/hepatic disease

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Egypt · 1 center
  • Cairo University — Giza

Identifiers

NCT: NCT07236580 · IRB00014233-50

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗